Zepbound tirzepatide injection, commonly used for chronic weight management
Wegovy follows with 9.6-15% weight loss, while Ozempic users typically experience 10-15% reduction
Supports Patients in Choosing At TrimBody M.D, we guide patients with care while they think about using GLP-1 therapy
GLP-1 receptor agonists are medications that increase the levels of this hormone in the body and restore its beneficial effects on blood sugars, sensations of fullness, and weight management
GLP-1 receptor agonists e.g., semaglutide, liraglutide commonly cause gastrointestinal adverse effects such as nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose escalation, less common risks include pancreatitis, gallbladder disease, and hypoglycemia mainly with insulin sulfonylureas
We proudly care for patients from Pelham, Larchmont, and the surrounding communities, offering personalized attention in a welcoming and professional environment